| 細胞名 | 病名 | 採取時年齢 | 性別 | 体細胞 | 臨床情報 | |
|---|---|---|---|---|---|---|
| ALS60E1 | Neuronal intranuclear inclusion disease (NIID) | 63 | M | fibroblast | 詳細表示 | |
| NIHDS2E1 | Neuronal intranuclear inclusion disease (NIID) | 73 | M | fibroblast | 詳細表示 | |
| NIHDS3EL1 | Neuronal intranuclear inclusion disease (NIID) | 69 | F | PBMC | 詳細表示 | |
| NIHDS4EL1 | Neuronal intranuclear inclusion disease (NIID) | 37 | M | PBMC | 詳細表示 | |
| FX1EL3 | Fragile X syndrome | 46 | F | PBMC | 詳細表示 | |
| FX2EL16 | Fragile X syndrome | 17 | M | PBMC | 詳細表示 | |
| FX6EL1 | Fragile X syndrome | 23 | M | PBMC | 詳細表示 | |
| FX8EL1 | Fragile X syndrome | 4 | M | PBMC | 詳細表示 | |
| FXTAS1EL1 | Fragile X-associated tremor/ataxia syndrome (FXTAS) | 82 | M | PBMC | 詳細表示 | |
| FXTAS2EL1 | Fragile X-associated tremor/ataxia syndrome (FXTAS) | 58 | M | PBMC | 詳細表示 | |
| MyD1 ⑩/HPS1032 | Myotonic dystrophy | 30s | M | PBMC | 詳細表示 | |
| MyD2 ②/HPS1051 | Myotonic dystrophy | 30s | F | PBMC | 詳細表示 | |
| MyD5 ⑬/HPS1052 | Myotonic dystrophy | 30s | M | PBMC | 詳細表示 | |
| MyD3 ⑦/HPS1033 | Myotonic dystrophy | 30s | M | PBMC | 詳細表示 | |
| HD1E6 | Huntington's disease | 60s | M | fibroblast | 詳細表示 | |
| SCD37EL2 | Spinocerebellar ataxia type 31 | 54 | F | PBMC | 詳細表示 | |
| SCD4 E2 | Spinocerebellar ataxia type 36 | 64 | M | fibroblast | 詳細表示 | |
| SCD10 9E/HPS0422 | Spinocerebellar ataxia type 36 | 60 | M | PBMC | 詳細表示 | |
| SCD20 E1 | Spinocerebellar ataxia type 36 | 65 | F | PBMC | 詳細表示 | |
| CANVAS1EL1 | cerebellar ataxia with neuropathy and vestibular areflexia syndrome | 68 | M | PBMC | 詳細表示 | |
| EPI5EL3 | Benign adult familial myoclonus epilepsy (BAFME) | 63 | F | PBMC | 詳細表示 | |
| EPI18EL2 | Benign adult familial myoclonus epilepsy (BAFME) | 43 | M | PBMC | 詳細表示 | |
| EPI20EL2/HPS3911 | Benign adult familial myoclonus epilepsy (BAFME) | 15 | M | PBMC | 詳細表示 | |
| EPI21EL2/HPS3914 | Benign adult familial myoclonus epilepsy (BAFME) | 15 | M | PBMC | 詳細表示 |